News

Biocon has announced a three-fold increase in profit at INR74 crore for the quarter ended 30 September, up from INR25 crore in the same period last year.The company’s

Potentia Pharmaceuticals it has entered into licensing and purchase option agreements with Alcon Research, a wholly-owned subsidiary of Alcon. The agreements provide Alcon with a license to develop

IRIS International has received Institutional Review Board (IRB) approvals from Duke University Medical Center, Memorial Sloan Kettering Cancer Institute, Eastern Virginia Medical School and the University of Washington

Ingenuity Systems has developed a new gene expression workflow with Life Technologies. The workflow leverages Ingenuity’s IPA software, the Applied Biosystems SOLiD System, TaqMan Gene Expression Assays and

EpiCept is expected to release the new findings demonstrating the pharmacoeconomic benefits of Ceplene (histamine dihydrochloride) for the remission maintenance of Acute Myeloid Leukemia (AML) patients in first

Elron has announced that a non-binding indication of interest of a third party regarding a potential acquisition of Medingo, an Elron subsidiary, has been received. The company claims

Quark Pharmaceuticals (Quark) has reported the issuance of Japanese Patent Number: 4354633, titled, ‘Hypoxia regulated genes,’ on August 7, 2009. Granted to Quark from a Japanese National Phase

Apogee Technology has announced the publication of an article on its intradermal immunization approach in the Online Early Edition of PNAS (the Proceedings of the National Academy of

A new study published in the Proceedings of the National Academy of Science (PNAS) has identified a new protein, BAHD1, which is responsible for changing DNA structure and